Preclinical pharmacology of ropinirole (SK&F 101468-A) a novel dopamine D2 agonist
- 1 January 1991
- journal article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 38 (1) , 147-154
- https://doi.org/10.1016/0091-3057(91)90603-y
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Drugs acting on brain dopamine receptors: A conceptual re-evaluation five years after the first selective D-1 antagonistPharmacology & Therapeutics, 1989
- MK 458, A Selective and Potent D2 Receptor Agonist in Advanced Parkinsonʼs DiseaseClinical Neuropharmacology, 1988
- SUBCUTANEOUS APOMORPHINE IN PARKINSONIAN ON-OFF OSCILLATIONSThe Lancet, 1988
- Closer to Parkinson's disease: MPTP and the aging nervous systemTrends in Pharmacological Sciences, 1987
- LISURIDE INFUSION PUMP: A DEVICE FOR THE TREATMENT OF MOTOR FLUCTUATIONS IN PARKINSON'S DISEASEThe Lancet, 1986
- (+)-4-PROPYL-9-HYDROXYNAPHTHOXAZINE (PHNO), A NEW DOPAMINOMIMETIC, IN TREATMENT OF PARKINSONISMThe Lancet, 1985
- 4-[2-(Di-n-propylamino)ethyl]-2(3H)-indolone: a prejunctional dopamine receptor agonistJournal of Medicinal Chemistry, 1985
- The “On–Off” Phenomenon in Parkinson’s DiseaseNew England Journal of Medicine, 1984
- ON-OFF FLUCTUATIONS IN PARKINSON'S DISEASEBrain, 1984
- "ON-OFF" EFFECTS IN PATIENTS WITH PARKINSON'S DISEASE ON CHRONIC LEVODOPA THERAPYThe Lancet, 1976